KELLY DIAZ: Open Payments
NPI 1568029437 · CHARLTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 23 payments from 12 companies in 2025. Trend: 2023 $166 · 2024 $302 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $163 |
| Novo Nordisk Inc | 2 | $50 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Hologic Sales and Service, LLC | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Lilly USA, LLC | 1 | $32 |
| Exact Sciences Corporation | 2 | $30 |
| Astellas Pharma US Inc | 1 | $29 |
| ALK-Abello, Inc | 1 | $24 |
| Amgen Inc. | 1 | $23 |
Products named: FARXIGA, TRELEGY ELLIPTA, MOUNJARO, Ozempic, Veozah, NEFFY, APTIMA, M-M-R II.
Industry payments across MA — which companies pay providers there.
